In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1910 News Items found
scientific image of lung cancer
Using Nanoparticles To Target Fibrosis in Cancer and Other Diseases

Scientists at MSK have developed a new nanoparticle-based approach to breaking down fibrosis in cancer and other diseases, which could make immunotherapy more effective. Learn about their findings in laboratory models.
Family of four sitting and smiling for camera.
Metastatic Breast Cancer and Motherhood

Learn how MSK's expertise in metastatic breast cancer helped a mother celebrate a long-awaited milestone with her family.
Agnel Sfeir
Scientists Uncover an Achilles’ Heel in Cancer’s ‘Rogue DNA’

MSK researchers have discovered that a type of rogue DNA found in aggressive cancers has a hidden structural weakness — and that blocking a single repair protein can cause it to fall apart, suggesting a new therapeutic opportunity.
MSK breast cancer specialist Pedram Razavi, MD, PhD.
Article
Latest Research Into Overcoming Resistance to Breast Cancer Targeted Therapies

Learn how MSK's researchers are making important strides in overcoming breast cancer resistance.
MSK medical oncologist Komal Jhaveri
Article
FDA Expands Approval for Imlunestrant To Treat ER+, HER2-, ESR1-mutated Advanced Breast Cancer That Resists Standard Therapy

Read about a new FDA-approved treatment for people with some ER+, HER2- advanced breast cancers.
GSK student Zaza Gelashvili
2026 GSK Chairman’s Prize Recognizes Research on How Cells Sense Injury

This year's GSK Chairman’s Prize was awarded to Zaza Gelashvili for his research on how cells sense injury.
Doctor in white coat talking to a patient.
Feature
Testicular Cancer: Myths and Facts

Learn how testicular cancer is often misunderstood and why it is highly treatable.
Dr. Andrew Kobets
Meet Andrew Kobets, a Pediatric Neurosurgeon at MSK Kids

Andrew Kobets, a pediatric neurosurgeon and member of the MSK Kids team, has a passion for helping children and their families face the challenges of a cancer diagnosis.
MSK patient Anthony Valente and Dr. Alexander Drilon
FDA Approves Zidesamtinib for Lung Cancers With ROS1 Fusions

Zidesamtinib, a new drug that treats non-small cell lung cancer carrying a mutation called a ROS1 fusion, has been approved by the FDA.
MSK logo visible on sleeve of lab coat
Fueling the Next Generation of Biomedical Research

Sixteen exceptional early-career scientists are advancing groundbreaking biomedical research at MSK thanks to the generous support of MSK philanthropists. These postdoctoral researchers, selected for their innovative research proposals and scientific promise, represent the future of oncology discovery.